In this long-form post published on LinkedIn Pulse and titled “2 Major Benefits for Seed and Pre-seed Investments in Israeli Companies”, Einat Katzenell of Katzenell Dimant explains why Israeli companies qualifying as early stage companies under the amended Angels Law should consider applying for grants under the “early stage companies” Program 8.23 of the OCS.
I had the pleasure of working with Einat and providing Editorial Services for this piece.
Einat Katzenell is the Founding Partner of Katzenell Dimant and provides strategic and practical legal advice to hi-tech, life sciences and biotechnology entrepreneurs, investors, early stage and mature companies, academic institutions and business initiatives.
From the post: “2 Major Benefits for Seed and Pre-seed Investments in Israeli Companies“:
“When presenting your startup to potential investors, there are two advantages available under Israeli law that you might want to emphasize, which could make investing in your startup much more attractive, particularly at the seed and pre-seed stages.
The first advantage is the tax benefits under the “Angels Law”, and the second is the $1:$1 grant under the “early stage companies” OCS program.
The “Angels Law” in its original form failed to achieve its goals, as only a few companies and angel investors capitalized on the benefits offered by the Angels Law. This law was recently amended to extend the applicability of the tax benefits, and as of January 2016 also applies to investments in “early stage” companies. The amended Angels Law also solves issues of uncertainty for the investors in terms of qualifying for the tax benefits that was determined only 3 years after the investment took place.”
Link to the full post